RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified ...
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced the U.S. commercial launch of TRAUMAGEL®, a revolutionary plant-based ...
EQS-News: SANUWAVE Health, Inc. / Key word (s): Healthcare SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales 13.01.2025 / 13:36 CET/CEST The issuer is ...
EDEN PRAIRIE, MN - January 13, 2025 ( NEWMEDIAWIRE) - SANUWAVE Health, Inc. (the "Company" or " SANUWAVE ”) (OTCQB:SNWV), a leading provider of next-generation FDA-approved wound care products, is ...